MPO-IN-10
MPO-IN-10 is an orally active, selective, and irreversible inhibitor of myeloperoxidase (MPO), with an IC50 of 0.080 μM against human MPO. MPO-IN-10 exhibits higher selectivity for extracellular MPO over intracellular (neutrophil) MPO. MPO-IN-10 can be used in the study of inflammatory diseases such as vascular disorders.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 2922402-01-3
- Formule: C23H25N3O
- Masse moléculaire:359.46
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Activité biologique
-
Chemical Information
- Pureté et documentation
- Références
-
Help & FAQs
Activité biologique
MPO-IN-10 (Compound IN-4) inhibits immune complex-stimulated NETosis in human primary neutrophils with an IC50 of 0.147 μM[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
| Species | Dose | Route | CLplasma | Vdss | T1/2 | AUClast | Cmax | Tmax | Bioavailability |
|---|---|---|---|---|---|---|---|---|---|
| Mice[1] | 1 mg/kg | i.v. | 69 mL/min/kg | 10 L/kg | 1.1 h | 641 nM·h | / | / | / |
| Mice[1] | 10 mg/kg | p.o. | / | / | / | 338 nM·h | 101 nM | 1.3 h | 54 % |
| Rat[1] | 1 mg/kg | i.v. | 29 mL/min/kg | 8 L/kg | 2.5 h | 1574 nM·h | / | / | / |
| Rat[1] | 3 mg/kg | p.o. | / | / | / | 1672 nM·h | 183 nM | 2.5 h | ~100 % |
| Dog[1] | 0.3 mg/kg | i.v. | 9 mL/min/kg | 7.3 L/kg | 8.6 h | 4000 nM·h | / | / | / |
| Dog[1] | 3 mg/kg | p.o. | / | / | / | 4893 nM·h | 361 nM | 2 h | ~100 % |
MPO-IN-10 (10-100 mg/kg; oral gavage; single dose) exhibits a dose-dependent inhibition of plasma MPO activity in a mouse model of acute Western diet feeding[1].
MPO-IN-10 (approximately 30-250 mg/kg; oral gavage; 10 days) exhibits a dose-dependent inhibition of plasma MPO activity in mice fed a Western-style diet, with an IC50 of approximately 0.5 μM[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:C57BL/6j (male, 8 weeks old) treated thioglycolate broth[1]
-
Dosage:30, 150 mg/kg
-
Administration:i.g.; single dose
-
Result:Reduced plasma MPO activity by 69% at 30 mg/kg and reduced plasma MPO activity by ~100% at 150 mg/kg at 5 hours post-dose.
Chemical Information
-
CAS No. 2922402-01-3
-
Masse moléculaire 359.46
-
Formule C23H25N3O
-
SMILES
O=C1N(C2=CC=C(C=CN3)C3=C2)C[C@@H](C4=CC=C([C@H]5CCCN5)C=C4)[C@@H]1C
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
MPO-IN-10 Related Classifications
HY-186046 Related Classifications
Powered by Bioz